IDL Diagnostics AB is a Swedish company that develops and markets blood and urine sample tests. IDL specializes in oncology and bacteriology. The company has a CE-marked product portfolio, used in healthcare, and established in various markets. In oncology, IDL uses various biomarkers, TK1, and cytokeratins, to support the treatment of various cancers such as breast, prostate, and bladder cancer. IDL's product portfolio also includes a rapid bacteriological test for a simple and safe diagnosis of typhoid fever. IDL (IDLDX) is listed on Nasdaq First North Growth Market with Redeye AB as Certified Adviser. 


IDL Diagnostics AB (IDLDX)

Org chart

Teams

Offices

IDL Diagnostics AB (IDLDX)

Org chart

Teams

Offices

Related companies